Login
← Go Back
Dishman Carbogen Amcis
DCAL · Pharma > Pharmaceuticals & Drugs · Chairman: Janmejay R Vyas · MD: Arpit J Vyas · Listing date: Sept. 22, 2017 · Employees: 929 · Ahmedabad · http://imdcal.com
Stock Price vs Company Growth
1d
2.2%
1w
1.7%
1m
0.4%
3m
23.4%
6m
64.4%
1y
69.6%
5y
0.8%
all
5.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 235 2.2%
184
283
Company Overview
Sales
2,580 Cr
Growth: 10.0%
Profit after Tax
-154 Cr
Growth: 223.6%
Small Cap
3,678 Cr
P/S: 1.4x
Industry P/S: 2.5x
Fundamentals
Sales (Cr) ₹ 2,580
Growth 10.0%
EBITDA 10.7%
P/S 1.4x
Dividend 0.0%
P/E -23.9x
Book Value ₹ 365
PEG Ratio -2.3x
ROE -2.7%
P/B 0.6x
Shareholding Pattern
Institutions
L And T Mutual Fund Trustee Ltd-L And T Flexicap Fund
2.9 %
Mukul Agrawal
2.55 %
Government Pension Fund Global
2.33 %
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund
1.88 %
Hbm Healthcare Investment(Cayman) Ltd.
1.62 %
Promoters
Adimans Technologies Llp
59.32 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.
Belongs to (9 Indices) view more
Investors (53)
jhunjhun...
tata.bal...
icici.pr...